AGYTF Stock Latest News
Company AnnouncementsAllergy Therapeutics Accelerates Growth on Grassmuno Launch and New Funding3M ago
Company AnnouncementsAllergy Therapeutics Names Executive Chairman as It Weighs Dual Hong Kong Listing3M ago
Company AnnouncementsAllergy Therapeutics Links CFO Incentive Award to Share Price and Growth Targets4M ago
Company AnnouncementsAllergy Therapeutics Highlights Positive Allergy Trial Data at EAACI 20264M ago
Company AnnouncementsAllergy Therapeutics boosts funding as Grassmuno launch and peanut vaccine advance7M ago
Company AnnouncementsAllergy Therapeutics Reshapes Major Shareholding Ahead of Potential Hong Kong Listing7M agoCompany AnnouncementsAllergy Therapeutics’ VLP Peanut Shows Strong Immune Response in Early-Stage Trial8M ago
Company AnnouncementsAllergy Therapeutics showcases new allergy immunotherapy data at AAAAI 20268M ago
- Company AnnouncementsAllergy Therapeutics seals £40m Hayfin facility and simplifies capital structure8M ago
- Company AnnouncementsAllergy Therapeutics Bolsters Board and Strategy Team to Drive Global Expansion9M ago
Company AnnouncementsAllergy Therapeutics Wins Strong Shareholder Backing at 2026 AGM9M ago- Company AnnouncementsAllergy Therapeutics Grants Performance-Linked Share Options to Senior Management9M ago
Company AnnouncementsAllergy Therapeutics lifts revenues and launches Grassmuno as German TAV transition accelerates9M agoCompany AnnouncementsAllergy Therapeutics Adds Asia-Focused Expertise to Board Ahead of Potential Hong Kong Listing9M ago
Company AnnouncementsAllergy Therapeutics Wins Shareholder Mandate for Potential Equity Raise Ahead of Hong Kong Dual Listing10M ago
- Company AnnouncementsAllergy Therapeutics Secures German Approval for Grassmuno® Immunotherapy10M ago
Company AnnouncementsAllergy Therapeutics Gains German Approval for Grassmuno Immunotherapy10M ago
Company AnnouncementsAllergy Therapeutics Plans Potential Equity Raise Ahead of Hong Kong Listing10M ago
Company AnnouncementsAllergy Therapeutics Reports Stable Financials and Strategic Growth Initiatives10M ago
Company AnnouncementsAllergy Therapeutics Achieves Key Milestone in Peanut Allergy Treatment Trial10M agoCompany AnnouncementsAllergy Therapeutics Considers Dual Listing on HKEX to Expand Asian Market Presence12M ago
Company AnnouncementsAllergy Therapeutics Advances Phase III Trial for Paediatric Grass Allergy Treatment1y ago
